CD274 and diabetes mellitus: As shown in Fig. 1b, c, anti-PD-L1 antibody-induced diabetes in 16 of 25 (64%) NOD mice [MSC(−) group], whereas systemic hMSC administration decreased the incidence of overt diabetes to four of 21 (19%) and resulted in significantly lower mean blood glucose levels (Fig. 1b).